Expansion of pan-cancer mismatch repair testing: Implications for pembrolizumab eligibility and Lynch syndrome screening

Cancer. 2024 Oct 29. doi: 10.1002/cncr.35624. Online ahead of print.

Author

Chong-Jie Zhang¹

Affiliation

¹ Department of Colorectal Surgery, Ningbo No. 2 Hospital,, Ningbo, Zhejiang Province, China.

PMID: 39470374
DOI: 10.1002/cncr.35624

No abstract available

Publication types

Letter

Grants and funding

2022HMKY09/Ningbo Huamei Hospital, Chinese Academy of Sciences University